Results for "RBC Capital Markets"

RBC Capital Markets has upgraded OGE Energy stock, citing upcoming catalysts as the earnings and investment season begins.

RBC Capital Markets maintained its favorable rating for agricultural giant Corteva, anticipating positive market reception following the upcoming Vylor business spinoff.

RBC Capital Markets has identified and named its top investment pick within the business services sector. This recommendation provides guidance for investors looking at opportunities in this market segment.

RBC Capital Markets continues to hold a bullish view on the S&P 500, indicating a preference for U.S. markets and growth-oriented stocks.

ResMed has been downgraded by RBC Capital Markets, citing challenges anticipated for the company in fiscal year 2027.

RBC Capital Markets has initiated coverage on Centene (CNC), expressing a positive outlook and suggesting that the company's challenges from 2025 are now behind it.

RBC Capital Markets has established the highest price target for Astera Labs (ALAB) stock, with an accompanying analysis on how investors can capitalize on the memory trade.

RBC Capital Markets has increased its price target for Marvell Technology stock, citing strong performance and future growth prospects. This adjustment reflects a positive outlook from the investment bank.

DA Davidson and RBC Capital Markets have adopted a more cautious outlook on Home Depot (HD) after the company's recent earnings announcement.

BMO Capital has maintained its bullish stance on Linde (LIN), while RBC Capital Markets suggests there is room for upside in the company's guidance.

RBC Capital Markets has slightly trimmed its price target for ACADIA Pharmaceuticals, citing seasonal biotech headwinds. The firm also cut its price target for Galapagos NV to $28, while maintaining a Sector Perform rating ahead of its Q1 earnings.

RBC Capital Markets has adjusted its outlook for Becton Dickinson (BDX), trimming its estimates despite stable demand in the MedTech sector.

RBC Capital Markets has upgraded its rating for Asana (ASAN) stock, setting a new price target of $7.

RBC Capital Markets has initiated coverage of Sonida Senior Living with a 'Buy-equivalent' rating.

RBC Capital Markets has increased its stock price target for Canadian National (CN) for the year 2027, indicating a positive outlook for the railway company.

RBC Capital Markets has identified weaknesses in the housing market as a significant risk factor for Installed Building Products, Inc. (IBP).

RBC Capital Markets has raised its price target for Broadcom (AVGO), citing bullish commentary regarding the company's financial outlook for fiscal year 2027.

RBC Capital Markets has issued a note indicating that CareTrust REIT, Inc. (CTRE) is well-positioned, even amid increased general and administrative expenses and investment timing considerations.

Ares Management Corporation is scheduled to present at the 2026 RBC Capital Markets Global Financial Institutions Conference, likely to discuss its financial performance and outlook.

RBC Capital Markets has downgraded Imperial Oil, citing that the company's valuation has become 'stretched' following several years of strong stock performance.

Investment bank RBC Capital Markets has begun tracking BorgWarner, issuing an initial buy rating as the company navigates its current market position.

RBC Capital Markets has given Atlassian an outperform rating, pointing to sustained upward momentum and strong technical indicators following the stock's recent rally.

RBC Capital Markets has increased price targets for several software stocks, including Snowflake and CrowdStrike, in anticipation of their upcoming earnings reports.

Lori Calvasina, head of US equity strategy at RBC Capital Markets, discusses current stock market sentiment, noting investor nervousness but no signs of panic.

According to RBC Capital Markets' Frances Donald, underlying inflation pressures persist, casting a shadow over the Federal Reserve's economic outlook and policy decisions.

RBC Capital Markets has begun its coverage of GE HealthCare Technologies Inc. (GEHC), indicating new analyst attention on the company's stock.

Vertical Research has upgraded Albemarle (ALB) to a bullish rating, while RBC Capital Markets reiterated its Outperform rating for the company.

RBC Capital Markets suggests that Radian's (RDN) acquisition of Inigo could lead to higher earnings growth for the company.

RBC Capital Markets has reduced its price target for IBM but continues to hold a bullish rating on the stock.

RBC Capital Markets has maintained its 'Underperform' rating for 3M (MMM), indicating a belief that the company has limited upside potential.

RBC Capital Markets has increased its price target for Vertex Pharmaceuticals (VRTX) as it updates its outlook for the biotech sector. This reflects a positive analyst sentiment towards the company.

RBC Capital Markets has adjusted its price targets for several companies, trimming Procter & Gamble's target due to modest growth while lifting Chevron's target as its commodity view improves.

RBC Capital Markets has reduced its price target for UBS while simultaneously adjusting its assumptions regarding the bank's Assets Under Management (AUM).

RBC Capital Markets has reiterated its 'Outperform' rating for Merck (MRK), acknowledging investor concerns regarding a 'modest premium' but maintaining a positive outlook for the pharmaceutical company.

RBC Capital Markets has identified Revolution, Xenon, and Arrowhead as leading candidates for potential takeovers, according to a recent report.

RBC Capital Markets has set a price target of $45 for Kinross Gold (KGC), outlining the conditions required for the stock to reach this valuation.

RBC Capital Markets has lowered the price target for Sweetgreen, Inc. (SG) due to a same-store sales outlook that is trailing behind consensus estimates.

RBC Capital Markets has increased its price objective for The Bank of Nova Scotia (BNS), citing an improving credit outlook for the bank.

Ares Management Corporation to Present at the 2026 RBC Capital Markets Global Financial Institutions Conference  The Globe and Mail

RBC Capital Markets has initiated analyst coverage for Revvity, 10X Genomics, and Mettler-Toledo, assigning a Sector Perform rating to all three companies as it expands its research footprint in the life sciences sector.

Analysts from Barclays and RBC Capital Markets predict that European defense company stocks will continue to grow rapidly in the coming years, as the region enters a new phase of increased defense spending.

RBC Capital Markets has raised its rating on Equinor, citing a more supportive market environment that provides the company with breathing room.

RBC Capital Markets has initiated coverage on NiSource with an Outperform rating, highlighting Indiana as one of the best data center markets in the Midwest.

RBC Capital Markets highlights that Varonis Systems' emphasis on data security and governance is becoming increasingly crucial in the evolving landscape of the artificial intelligence era.

RBC Capital Markets has cut its rating for Rio Tinto to 'Sell' equivalent, citing expectations for a continued decline in iron ore prices.

RBC Capital Markets predicts that any potential pullback in the S&P 500 index is likely to be limited to a range of 5% to 10%, offering a cautious outlook on market volatility.

RBC Capital Markets upgraded an unnamed steakhouse chain to outperform, citing increased restaurant traffic and declining beef prices as positive indicators for the sector.

RBC Capital Markets has maintained its Outperform rating on Linde plc (LIN), indicating continued confidence in the company's financial performance and stock potential.

RBC Capital Markets has upgraded its rating for Unilever (UL) stock from its previous position to 'Sector Perform'. This change reflects a revised outlook on the consumer goods giant's market performa

RBC Capital Markets has downgraded the ratings for oilfield services companies NOV and Trican Well Services.

RBC Capital Markets has downgraded Ivanhoe Mines' stock rating, citing expectations of materially lower near-term production for the mining company.

RBC Capital Markets has maintained its Outperform rating on Union Pacific (UNP), while also flagging higher Q1 EPS and potential approval risks for the railway company.

Lofty investor expectations for growth and a balanced risk-reward ratio make shares of Starbucks less compelling, according to RBC Capital Markets.

RBC Capital Markets has reiterated its Outperform rating for Nike (NKE), indicating a positive outlook and seeing a clear path to growth for the sportswear giant.

RBC Capital Markets has reduced its price target for Leidos Holdings, Inc. (LDOS) from $230 to $215, citing a service-focused valuation.

RBC Capital Markets has upgraded its rating for pharmaceutical company AbbVie to 'outperform,' citing expectations for durable growth.